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Abstract 
Due to the difficulties in production and purification of G-protein coupled receptors (GPCRs), 
relatively little structural information is available about this class of receptors. Here we aim at 
developing small chimeric proteins, displaying the extracellular ligand-binding motifs of a human 
GPCR, the Y receptor. This allows the study of ligand-receptor interactions in simplified 
systems. We present comprehensive information on the use of transmembrane (OmpA) and 
soluble (Blc) !-barrel scaffolds. While Blc appeared to be not fully compatible with our 
approach, due to problems with refolding of the hybrid constructs, loop-grafted versions of 
OmpA delivered encouraging results. Previously, we described a chimeric construct based on 
OmpA displaying all three extracellular Y1 receptor loops in different topologies and showing 
moderate affinity to one of the natural igands. Now, we present detailed data on the interaction of 
these constructs with several Y receptor ligands along with data on new constructs. Our findings 
suggest a common binding mode for all ligands, which is mediated through the C-terminal 
residues of the peptide ligand, supporting the functional validity of these hybrid receptors. The 
observed binding affinities, however, are well below those observed for the natural receptors, 
clearly indicating limitations in mimicking the natural systems. 
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Introduction 
G-protein coupled receptors (GPCRs) represent one of the most important classes of cell-
surface receptors and constitute prevalent targets for pharmaceutical drugs (Tyndall and Sandilya, 
2005; Congreve and Marshall, 2010). The crystal structures of several GPCRs (Katritch et al., 
2012) have deepened our understanding of this biologically important class of proteins. 
The structure of GPCRs can be described as an extracellular N-terminal domain, attached to a 
heptahelical segment embedded in the plasma membrane, which is followed by a cytosolic 
domain. The seven transmembrane (TM) helices are on either side connected by three intra- (i1 to 
i3) or extracellular (e1 to e3) loops, respectively. While the overall topology of the heptahelical 
bundle is generally conserved in GPCRs with known structure, the extracellular loops are largely 
unstructured (for a comparison see the review by Hanson et al. (Hanson and Stevens, 2009) and 
Peeters et al. (Peeters et al., 2011)). Furthermore, increased crystallographic B-factors in the 
extracellular loops are often observed. Conformational flexibility has been interpreted to play a 
role for ligand-binding (Koshland, 1958). 
Ligands of those GPCRs whose X-ray structures have been determined recently are usually 
small molecules that bind to a pocket among the helix bundle within the transmembrane region. 
Only one high-resolution structure of a GPCR bound to a small peptidic antagonist is available so 
far (Wu et al., 2010). In general, peptide ligand binding sites are believed to be part of the 
extracellular loops and the extracellular N-terminal domains (Lagerstrom and Schioth, 2008). 
Despite recent progress in X-ray structure elucidation, the expression, purification and 
refolding generally still present major hurdles in the structural study of GPCRs. Successful NMR 
studies of GPCRs are yet missing. This is only in part due to the inherent problems of NMR for 
the investigation of large molecules, such as line broadening and signal overlap. In addition, slow 
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conformational dynamics often severely deteriorate the quality of the spectra. 
In the light of the fundamental problems for studying entire GPCRs by solution NMR, we aim 
at establishing a model system in which the extracellular loops of a peptide-binding GPCR are 
grafted onto a robust protein scaffold that is better amenable to NMR spectroscopy than the 
heptahelical TM bundle. Such a scaffold should i) display all loops in a favorable topology, ii) be 
expressible in high yields in a microbial host, and iii) be easy to purify, solubilize, and/or refold. 
Such a chimeric receptor may be useful for pharmacological studies with regard to the strength 
and specificity of ligand binding or to the competitive binding behavior between various agonists 
and antagonists. 
Recently, we described the development of a model that mimics the extracellular domains of 
the human Y receptors based on a !-barrel scaffold from the E. coli outer membrane protein A 
(OmpA) (Walser et al., 2011). The model takes advantage of the membrane-integral !-barrel fold 
of OmpA and displays grafted loops in a favorable topology. The Y receptors are targeted by 
neurohormones from the neuropeptide Y family: neuropeptide Y (NPY), peptide YY (PYY) and 
pancreatic polypeptide (PP) (Larhammar, 1996a). So far four different subtypes of receptors have 
been characterized (Y1, Y2, Y4, and Y5 (Larhammar, 1996b; Larhammar and Salaneck, 2004)) 
which are associated with different pharmacological effects. In these, the three extracellular 
loops, and possibly also the N-terminal domain, are proposed to be involved in ligand binding 
(Zou et al., 2008). 
We now describe the development of this receptor model in much more detail. As scaffolds 
we have initially employed two different, yet structurally related !-barrel proteins, the soluble 
bacterial lipocalin (Blc) (Bishop, 2000; Schiefner et al., 2010) and OmpA (Tamm et al., 2003) 
from E. coli. We demonstrate that all three extracellular Y1 receptor loops and its N-terminus can 
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be successfully transferred to the OmpA scaffold. 
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Results 
Design aspects 
So far structural details at atomic resolution are available for nine major different GPCRs (for a 
summary see Supp. Mat.). We selected the N-termini and extracellular loops of the Y receptors 
based on the predicted topology as annotated in the GPCRDB (e.g. 
http://www.gpcr.org/7tm/proteins/npy1r_human for the human Y1 receptor). In the case of the 
human Y1 receptor the extracellular loops comprise 13 and 14 residues for e1 (Y99 to M111) and 
e3 (F284 to N297), respectively, and 34 residues for e2 (Q176 to S209). The predicted N-
terminal domains of the Y1, Y2, and Y4 receptors are the first 40, 50 and 41 residues, 
respectively. 
The rationale for the design of the loop-grafted receptor models was as follows: First, we 
defined anchor points as the positions of the terminal C" atoms of the "-helix or the !-strand that 
is connected to a loop. The mutual distances between these anchor points define the overall 
topology of the set of extracellular loops. Figure 1 depicts a comparison of the distances between 
the anchor points on the extracellular side for a set of 10 different GPCR crystal structures with 
known structure at the onset of our study (for a list see Materials and Methods). The spacing 
between the anchor points for the three extracellular loops is on average 13 Å for e1 and e2 and 
14 Å for e3, with a narrow distribution of +/- 3 Å. The distances between anchor points that are 
not part of the same loop are much less conserved, indicating that the relative positions of two 
helices anchoring the same extracellular loop is more conserved than the relative positions 
between helices not directly connected.  
A similar analysis was conducted for the available high-resolution structures of Blc 
(Campanacci et al., 2004; Schiefner et al., 2010) and OmpA (Pautsch and Schulz, 1998; Pautsch 
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and Schulz, 2000). Since both published OmpA X-ray structures lack defined electron density for 
a substantial number of residues located in the extracellular loops we mostly relied on the NMR 
structures for this protein (Arora et al., 2001; Cierpicki et al., 2006). Figure 1 depicts a statistical 
analysis of the distances observed in the crystal structure of Blc (Campanacci et al., 2004) and the 
ten lowest energy conformers of two NMR structures of OmpA (Arora et al., 2001; Cierpicki et 
al., 2006) as well as a shortened loop construct of the OmpA scaffold (Johansson et al., 2007). 
A comparison of the pairwise distances between anchor points in GPCRs and these scaffold 
proteins revealed that the distance distribution observed in the GPCRs falls within the 
distribution observed for the OmpA structures and is also close to the distances observed for Blc, 
suggesting that the !-barrels of Blc and OmpA might indeed provide suitable frameworks for 
grafting the extracellular loops of GPCRs. While the distances between directly connected anchor 
points are between 10 and 17 Å in OmpA, in Blc those distances are significantly shorter: 
roughly 5 Å for three anchor point pairs and 10 Å for the fourth pair. GPCRs possess 3 whereas 
OmpA carries 4 extracellular loops, leaving at least one "acceptor" site in the scaffold 
unoccupied. In order to rule out interference with the remaining native loop, it was replaced by a 
minimal turn-inducing motif of 1-2 residues compatible with the OmpA !-barrel structure 
(Koebnik, 1999a). 
 
Blc construct design 
We have previously demonstrated that the extracellular N-terminal domain of the Y4 receptor 
(NY4) interacts with PP (Zou et al., 2008; Zou et al., 2009). Because of its well-behaved nature 
in terms of expression and stability we have initially chosen the Y2 receptor N-terminus (NY2) 
for our studies aiming at determining suitable attachment points to the Blc scaffold. Accordingly, 
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we fused the NY2 domain to different positions in the N-terminal region of Blc. In these 
constructs varying portions of the Blc N-terminus were replaced with NY2 in order to test how 
close a grafted N-terminal sequence can be brought to the first strand of the Blc !-barrel, without 
impairing its fold. The tolerance of the scaffold towards the fused sequence was judged by 
[15N,1H]-HSQCs (see Figure 2). Moving the fusion point between NY2 and Blc too close to the 
characteristic 310-helix (less than 10 residues) that in many lipocalins precedes the !-barrel 
(Flower et al., 2000) resulted in insoluble constructs, whereas fusion at more N-terminal positions 
was well tolerated. However, no interaction of these chimera with NPY family neurohormones 
could be detected. We also attempted to investigate whether the interaction detected between 
NY4 and PP (Zou et al., 2008) could be reproduced in the context of the Blc scaffold, but no 
stably folded fusion protein with NY4 could be obtained (data not shown). We also set out to 
incorporate the extracellular loops of the Y1 receptor (e1Y1 to e3Y1), but the Blc scaffold did not 
tolerate the necessary modifications in its loops. 
 
OmpA construct design 
 Our initial studies concentrated on probing the compatibility of the Y receptor extracellular 
loops with the OmpA scaffold. Considering that most of the data from mutagenesis studies are 
available for the Y1 receptor we exchanged each of the four extracellular loops of OmpA with 
each of the three eY1 loops individually to generate altogether twelve constructs, dubbed “one-
loop exchange constructs”. Further, we constructed a series of OmpA mutants in which a single 
eY1 loop was grafted into one OmpA acceptor site while the other three sites were filled with a 
minimal turn-inducing motif (Koebnik, 1999b). These were called “one-loop graft constructs”. 
All constructs could be expressed in E. coli, solubilized in urea and refolded (see Figure S1 in the 
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Supp. Mat.), indicating that OmpA is suitable as a generic scaffold for grafting individual eY1 
loops, both in the presence and absence of the other three of its natural loops. 
In principle, the set of three eY1 loops can be arranged in 24 different ways (4x3x2) on the 
OmpA scaffold according to this approach. To avoid unsuitable constructs when combining the 
individually grafted loops we calculated a "mismatch score" accounting for the distance 
mismatches of all relevant anchor points between the model scaffold and the GPCRs (see Figure 
3). Among the candidates with low mismatch scores, only those with a correct topological loop 
arrangement (i.e. the C-terminus of e1 to be followed by the N-terminus of e2 in a clockwise 
manner and so on) were considered. Four of those arrangements were selected and will be 
referred to in the following as “receptor constructs”, abbreviated as Y1L1, Y1L2, Y1L3 and 
Y1L4 (see Figure 3). 
The initial topological analysis of the anchor point distances revealed that although the 
pairwise distances for each loop in the known GPCR structures fall within the range of those 
observed in OmpA, the overall match is not perfect. To account for these structural differences 
additional flexible linker residues at the termini of the loops were introduced by inserting 
glycine-serine spacers of different lengths. Based on the Y1L3 topology six constructs were 
designed: two in which each Y1 receptor loop was flanked on both sides by a Ser-Gly dipeptide 
or a Ser-Gly-Ser-Gly tetrapeptide (Y1L3-GS and Y1L3-GSGS), respectively, two where only the 
short e1- and e3-loops were flanked by these spacers (Y1L3-gs and Y1L3-gsgs), and two where 
only the longer e2-loop was equipped with the spacers (Y1L3-e2gs and Y1L3-e2gsgs). 
Notably, all these constructs lack the N-terminal receptor domain, which may also be involved 
in ligand binding (Robin-Jagerschmidt et al., 1998; Wieland et al., 1998; Zou et al., 2008). 
Unfortunately, in OmpA the N-terminus of the !-barrel is located opposite to the (extracellular) 
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face used for grafting. We inserted the sequence of the N-terminal Y1 receptor domain (NY1) 
into the third, so far “empty” acceptor position of Y1L3, flanked by an N-terminal (Gly-Ser)3 and 
a 3C protease cleavage site, allowing the in situ generation of a free N-terminus via proteolytic 
cleavage after refolding (construct Y1L3-NY1 in Figure 3). 
 
Biosynthetic aspects of hybrid GPCR-OmpA constructs 
All these constructs were purified, solubilized and refolded in unlabeled and 15N-labeled form 
from inclusion bodies produced in E. coli with yields of ~200 and ~100 mg per liter of LB rich 
medium or 15N-labeled M9 minimal medium, respectively. The folding state of OmpA was 
monitored by SDS-PAGE in which the sample was mixed with SDS sample buffer but not heated 
prior to loading on the gel, leaving the OmpA fold intact and referred to here as “non-denaturing 
SDS-PAGE” (Reithmeier and Bragg, 1974; Schweizer et al., 1978). During refolding screens, 
solutions of the urea-denatured chimeric OmpA were diluted into different buffers containing 
various detergents at concentrations above their critical micellar concentrations (cmc) and at 
detergent/protein ratios >500 (for a list of the relevant biophysical parameters see Table S1 in the 
Supp. Mat.). 
All of the 12 "one-loop exchange constructs" and 6 of the "one-loop graft constructs" as well as 
the 4 selected "receptor constructs" were expressed, purified and their refolding capability was 
assessed by non-denaturing SDS-PAGE (see Figure 4). While the expression level of all 22 
constructs was similar to that of wild type (wt)-OmpA, the refolding efficiency was clearly lower 
for some these constructs. Nevertheless, each of the 22 constructs could be refolded at least to 
50% (data not shown). Generally, refolding efficiency increased with increasing pH 
(Kleinschmidt et al., 1999). While for some constructs rapid dilution of the urea-denatured 
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protein solution into detergent buffer at high pH 10.0 resulted in nearly complete refolding, some 
constructs required more gentle conditions of slow dilution at a lower temperature of 4°C. 
In the Y1L3-NY1 construct complete refolding under similar conditions of pH and detergent 
was possible (see Figure 5b). After refolding in DHPC micelles, Y1L3-NY1 was incubated with 
3C protease and the efficiency of cleavage and integrity of the !-barrel were assessed by 
denaturing and non-denaturing SDS-PAGE, respectively. As can be seen in Figure 5b, bands 
corresponded closely to the expected sizes. Y1L3-NY1 refolded in DHPC micelles showed the 
same electrophoretic mobility before and after treatment with 3C protease, indicating integrity of 
its tertiary fold even after cleavage. The appearance of two bands around 14 kDa and the 
concomitant complete disappearance of the band at 27 kDa under denaturing SDS-PAGE 
conditions proved that the proteolytic cleavage was highly efficient (for results with alternative 
detergents see Supp Mat. Figure S2). 
Whenever folded forms of the chimeric OmpA constructs were detected by SDS-PAGE, the 
presence of tertiary structure and formation of the !-barrel was also apparent from the large 
signal dispersion in the [15N,1H]-HSQC spectra of these preparations (for [15N,1H]-HSQC spectra 
of the four receptor constructs Y1L1-4 see Figure S3 in the Supp. Mat.). 
 
Interaction studies of neurohormones of the NPY family with chimeric Y1-OmpA receptor 
constructs 
Binding of NPY, PYY and PP to the receptor constructs was tested using chemical shift 
mapping or saturation transfer difference (STD) (Mayer and Meyer, 1999; Mayer and Meyer, 
2001) techniques. 15N-labeled neurohormones (for assignments see Table S2 in the Supp. Mat.) 
were titrated with unlabeled receptor constructs. The resulting changes for the NPY spectra upon 
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addition of 20 equivalents of the chimeric receptor constructs are depicted in Figure 6. No 
interactions could be detected with Y1L1 or Y1L2, whereas Y1L3 and Y1L4 induced significant 
changes in the [15N,1H]-HSQC spectra of NPY when present in excess. Interestingly, no shift in 
peak positions, but a decrease in peak intensities was observed. This finding is consistent only 
with an exchange process slow on the NMR timescale, which usually results in two sets of peaks, 
one corresponding to the bound and the other to the non-bound form. We suspect that excessive 
broadening of the resonances due to small conformational fluctuations in the receptor-bound state 
or a large number of different states that do not interconvert fast on the NMR time scale has led 
to the disappearance of the bound state signals.  
Figure 6 depicts the volume changes of the peaks from the neurohormones upon titration with 
an excess of Y1L3 (for similar results obtained with the SG linker versions see Supp. Mat. Figure 
S4). The data clearly indicate that the C-terminal residues of the peptide were much more 
affected by interaction with the chimeric receptor than those of the N-terminus. In agreement 
with previous studies (Beck-Sickinger et al., 1994) this indicated that the C-terminal "-helix of 
the neurohormone is involved in receptor binding. Despite the qualitative similarities of the peak 
volume changes between all three neurohormones tested, the attenuations were less pronounced 
for PYY and, in particular, for PP than for NPY. Considering that the binding profile of PP to the 
Y receptor subtypes has been shown to be different from the ones of NPY and PYY (Larhammar 
and Salaneck, 2004). This may indicate differences in the binding mode in our model system, 
too. 
Specificity of the interaction was corroborated by a competition experiment with unlabeled 
NPY (Figure 6c) (Walser et al., 2011). Furthermore, binding assays with NPY-R33L and NPY-
R35L, two mutants of NPY that exhibit much reduced affinity to the Y1 receptor in vivo (Beck-
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Sickinger et al., 1994), were conducted. These mutant NPY peptides displayed a markedly 
decreased affinity for Y1L3 as visible from the reduced attenuation of peaks for the C-terminal 
residues (see Figure 6d-g). In summary, these findings confirmed a specific interaction of the 
neurohormones of the NPY family with the chimeric GPCR-OmpA receptor construct Y1L3. 
Interestingly, the chemical shift mapping data from titration of 15N-NPY with cleaved or 
uncleaved Y1L3-NY1 showed a behavior very different from Y1L3, revealing shifts in the 
positions of certain peaks (see Figures 5c and S5 in the Supp. Mat.). Large chemical shift 
changes were exclusively observed in the C-terminal helix of NPY, showing a pronounced i+3 or 
i+4 periodicity, thus indicating an interaction involving residues located on the same side of the 
helix.  
STD experiments conducted with NPY in the presence of Y1L3 or cleaved Y1L3-NY1 showed 
the most pronounced saturation transfer effects for the aromatic resonances of peptide residues, 
which – with the exception of the N-terminal Tyr – are all located in the C-terminal half of NPY 
(Walser et al., 2011). 
In order to obtain further information on the ligand-receptor interactions, all four 15N-labeled 
receptor constructs Y1L1-4 were mixed with unlabeled NPY (see Figure S6 in the Supp. Mat.). 
Surprisingly, the [15N,1H]-HSQC spectra of the all chimeric receptor constructs did not display 
major changes upon addition of the neurohormone. We speculate that most peaks from the short 
e1 and e3 loops, which have been proposed to mediate interaction with the peptide hormones 
(Walker et al., 1994; Merten et al., 2007), are exchange-broadened beyond detection. This view is 
supported by the observation that the actual number of observed sharp peaks in the receptor 
constructs, which most likely originate from the flexible loops, is only ~40 out of an expected 60. 
To verify that resonances from the e1 and e3 loops are absent in the spectra of the receptor-
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peptide complexes we attempted to assign the backbone of Y1L3 using perdeuterated protein (see 
Supp. Mat. Figure S7). 
 
Characterization of the chimeric receptor species responsible for binding 
Because the refolding efficiency of the two apparently functional receptor constructs Y1L3 and 
Y1L4 was less than 100% it is a priori not clear whether it was the folded or the unfolded 
component of the mixture that showed interaction with the neurohormones in the NMR titration 
experiments. Given the lack of a method to fully separate the folded from the unfolded protein 
species we chose to produce Y1L3 under conditions that resulted in the completely unfolded 
chimeric receptor and repeated the chemical shift mapping experiments on NPY. To this end, 
"refolding" was performed at the favorable pH 10, however, in the presence of the detergent DPC 
which is incapable of inducing refolding. Addition of 30 equivalents of this unfolded Y1L3 
preparation in DPC to the NPY neurohormone had a much smaller effect than the addition of 20 
equivalents of the (partially) folded Y1L3 in the previous experiments using DHPC as detergent 
(see Figure S8 in the Supp. Mat.). 
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Discussion 
Peptide hormone binding to G-protein coupled receptors is largely mediated through 
association of the ligand with the extracellular receptor loops (Bockaert and Pin, 1999). 
Considerable biochemical information on the interactions of the Y receptors with their ligands 
exists. For example, a complete alanine scan for NPY revealed a drop in affinity toward the 
human Y1 receptor by about 4 orders of magnitude for point mutations at either Arg33 or Arg35 
(Beck-Sickinger et al., 1994). On the receptor side, acidic residues have been proposed to be 
involved in ionic interactions with these Arg residues of the peptide ligand, most prominently the 
highly conserved Asp6.59 at the interface of TM6 and e3 (Merten et al., 2007). In addition, it was 
recently proposed that transient contacts are formed by the peptide with the N-terminal receptor 
domain, facilitating transfer of the ligand from a membrane-associated state to the binding site of 
the receptor (Bader and Zerbe, 2005; Zou et al., 2008). 
To circumvent the biochemical and spectroscopic problems when studying entire GPCRs we 
tested whether the extracellular domains can be transferred onto a suitable more robust protein 
scaffold. Individual GPCR loop sequences have been investigated before as free peptides or 
attached to some support. For example, Yeagle and coworkers structurally characterized peptides 
corresponding to the extracellular loops of rhodopsin (Yeagle et al., 1997a; Yeagle et al., 1997b). 
Similarly, Mierke et al. synthesized peptides comprising the cytosolic loops of the PTH receptor 
(Mierke et al., 1996). Pham et al. described peptides that contained the sequence of the e1 loop of 
the sphingosine-1-phosphate receptor 4 (S1P4) flanked by soluble self-assembling segments that 
mimicked the helical N-terminus of TM 2 and the C-terminus of TM 3 (Pham et al., 2007). A 
conceptual disadvantage of these approaches is that the loop-constraining entities are themselves 
rather flexible. Hence, it was the purpose of the present study to provide a more rigid, three-
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dimensional scaffold that enforces orientation of the entire set of GPCR loops into a defined 
overall geometry. 
For the success of such an approach the proper choice of the protein scaffold is crucial 
(Skerra, 2000a). Examples of widely employed protein scaffolds include antibodies (i.e. the 
immunoglobulin fold represented by single Ig and Ig-like domains (Hudson and Souriau, 2003)), 
protease inhibitors such as Kunitz-type domains (Dennis and Lazarus, 1994), lipocalins (Skerra, 
2000b), natural (Brunet et al., 1993) and artificial helix bundles (Houston et al., 1996) as well as 
smaller peptides rich in disulfide bonds, so-called knottins (Smith et al., 1998). Eight-stranded !-
barrel proteins, both soluble and membrane embedded, display four extracellular loops and 
usually provide high folding stability (Skerra, 2000a; Schulz, 2002). Previous work has 
demonstrated that binding specificity for small and large molecules can be engineered into 
lipocalins by directed evolution (Skerra, 2000a; Kim et al., 2009; Schonfeld et al., 2009). 
However, our initial attempts to employ the bacterial lipocalin, Blc (Campanacci et al., 2004; 
Schiefner et al., 2010), as a scaffold for grafting the extracellular loops of the Y receptor, 
unfortunately resulted in mutants that could not be efficiently refolded. A likely explanation is 
that Blc itself has a particularly low thermal stability around 45°C. An interesting alternative 
candidate in this regard might be the newly discovered thermostable "slim lipocalin" from a 
Gram-positive bacterium (Wu et al., 2012). The absence of detergents and the concomitant 
decrease in molecular weight and lower complexity of the system offers attractive advantages for 
development of a soluble protein scaffold. 
Considering that binding of the neurohormones of the NPY family to the Y receptors has been 
postulated to occur from a membrane-bound state (Bader and Zerbe, 2005) a membrane-
embedded !-barrel scaffold seems to be more suitable despite the above-mentioned technical 
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problems with such systems. OmpA is structurally (Pautsch and Schulz, 2000; Arora et al., 2001) 
and biochemically (Ried et al., 1994; Kleinschmidt et al., 2011) well characterized, can be easily 
solubilized with detergents, and is of a size still amenable to routine NMR studies. 
It is likely that no single heterologous scaffold will perfectly match all the loop geometries 
encountered in GPCRs. Nevertheless, a statistical comparison of distances between loop anchor 
points in the solution structures of OmpA and in the available X-ray structures of GPCRs 
revealed that these distances fall into similar ranges. Taking into account the presumed plasticity 
of anchoring points in OmpA and the known flexibility of loop residues in the GPCRs, we 
believe that the !-barrel of OmpA should provide a viable scaffold to present the extracellular 
loops of many GPCRs. Remaining mismatches of distances in the model may be partially 
compensated by structural adaptation or by choosing appropriate linkers. 
The protein engineering studies described herein demonstrate that OmpA represents a 
biosynthetically suitable scaffold as most of its mutants could be successfully refolded. For all 
constructs studied the refolding efficiency generally increased at elevated pH, as previously 
observed for wt-OmpA (Surrey and Jahnig, 1992; Kleinschmidt et al., 1999). However, the 
chimeric receptors could not be refolded quantitatively. For all the four designed receptor 
constructs Y1L1-4 [15N,1H]-HSQC data indicate that the !-barrel has remained intact. This 
observation corroborates the notion by others (Johansson et al., 2007) and from our previous 
work (Walser et al., 2011) that OmpA can serve as a generic scaffold for loop grafting purposes. 
NMR chemical shift mapping techniques revealed that some of our chimeric receptor 
constructs indeed bind the cognate peptides with reasonable affinity. The fact that 15N-labeled 
NPY can be displaced from the chimeric OmpA receptor constructs with unlabeled NPY in a 
competition assay strongly argues in favor of a specific interaction with the ligand and against a 
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general mode of lipid association or other non-specific binding events (Walser et al., 2011). This 
fact is further corroborated by the observation that peptides with reduced affinities for the wild-
type Y receptors also bound with lower affinity to our recombinant receptor model. Also, the 
addition of wt-OmpA or of a minimal length OmpA with all four extracellular loops replaced by 
short, turn-inducing motifs (Koebnik, 1999a) failed to reveal an interaction. Finally, only some of 
the receptor constructs (Y1L3/Y1L4) bound the peptide ligands whereas others (Y1L1/Y1L2) did 
not, indicating that the precise arrangements of the loops is indeed important.. 
Due to the fact that the neurohormones bind to the micelles with micromolar dissociation 
constants (Lerch et al., 2005) a precise determination of the KD for binding the receptor construct 
is difficult to obtain. The observation of slow exchange on the NMR timescale in the chemical 
shift mapping experiments however allows to estimate that the affinities of the peptide ligands to 
the model receptor are lower by about 3 orders of magnitude when compared to the wild-type 
GPCRs (low micromolar vs. low nanomolar KD values). This reduced affinity is likely due to 
conformational imperfections of the OmpA scaffold, although we cannot exclude that residues 
not from the loops are additionally involved in binding. This argues for the fact that the exact 
loop arrangement is of utmost importance, and that already seemingly small deviations from an 
ideal geometry result in much reduced binding affinities. Therefore, even though OmpA might 
serve as a convenient platform for displaying the extracellular loops of GPCRs, it may not be 
possible to modify the system to reproduce in vivo binding affinities. 
It was previously demonstrated that the N-terminal domain of class A GPCRs are involved in 
ligand binding, too (Robin-Jagerschmidt et al., 1998; Wieland et al., 1998; Zou et al., 2008). 
Unfortunately, the topology of OmpA is such that its N-terminus is located on the periplasmic 
side and hence opposite to the grafted loops. We therefore inserted the sequence of NY1 into the 
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third extracellular loop position of the OmpA scaffold. Since the N-terminus of this receptor 
domain was still covalently linked to an anchor point we re-established the free N-terminus of 
NY1 by proteolytic cleavage with a site-specific protease after refolding/insertion of the chimeric 
Y1-OmpA protein into the DHPC micelle. Interestingly, in certain detergent micelles the cleaved 
construct was sufficiently stable even at elevated temperatures (47°C) to allow for extended 
NMR experiments. 
The chemical shift mapping experiments using 15N-NPY with the cleaved Y1L3-NY1 chimeric 
receptor revealed a different binding mode of both versions of this protein when compared to 
Y1L3. Again, chemical shift changes were exclusively observed in the C-terminal "-helix of 
NPY, but appeared clustered on the hydrophobic side of the helix. This indicates that the primary 
binding region is the same for all constructs while the exact binding mode is changed by the 
presence of NY1. 
 
 20 
0 
Materials and Methods 
Materials 
15NH4Cl, was from Spectra Stable Isotopes (Andover, Massachusetts, USA). DHPC was from 
Avanti Polar Lipids (Alabaster, Alabama, USA). All other chemicals were from Sigma-Aldrich 
(Buchs, Switzerland). 
All primers were purchased from Microsynth (Balgach, Switzerland). Primers for deletions 
were purchased as desalted oligos and used without further purification. Primers for the insertion 
constructs were self-made by PCR using two short, desalted oligos. PCR products were purified 
with a Sigma PCR clean-up kit (NA1020-1KT) and used in subsequent QuikChange mutagenesis 
reactions. The sequences of all constructs were confirmed by dideoxy sequencing (Sanger et al., 
1977) by Synergene Biotech GmbH (Zurich, Switzerland).  
 
Cloning and purification of the Blc-derived constructs 
The cDNA sequence of the human Y1, Y2 and Y4 receptors as obtained from the Missouri 
S&T cDNA Resource Center (www.cdna.org) were used as templates for the receptor N-terminal 
domains without further optimization.  
The plasmids coding for the constructs with the NY2 N-terminal domain inserted at positions 
preceding L11, T14, S20, N32, F34, and L40 were generated from pBlc3 (Schiefner et al., 2010) 
by an overlapping PCR strategy. The NY2 segment had to be inserted between the OmpA 
periplasmic signal sequence and the mature Blc sequence. This was achieved by generating via 
PCR three overlapping constructs comprising (1) the XbaI restriction site at the 5'-end of the 
expression cassette and the OmpA signal sequence (Skerra, 1994)), (2) the Y receptor N-terminal 
domain, and (3) the Blc core plus a HindIII restriction site at the 3'-end of the expression cassette. 
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The fragments were generated by standard PCR procedures using Vent DNA polymerase 
(Fermentas, Thermo Scientific, Wohlen, Switzerland). PCR products were analyzed and purified 
by 1.5% agarose gel electrophoresis containing ethidium bromide for DNA staining. A QiaGen 
gel purification kit was used for all PCR purifications. 500 ng of the resulting DNA fragments 
were digested with XbaI (5 U) and HindIII (10 U) in Tango buffer (Fermentas, Thermo 
Scientific, Wohlen, Switzerland) at 37°C for 2 h, purified on a 1.5% agarose gel and ligated with 
the pBlc3 vector backbone, obtained by digestion with XbaI and HindIII. The variants Blc-
NY2(T23) and -NY2(P25) were constructed using QuikChange mutagenesis. pBlc3-NY2S20 was 
used as the starting construct from which 3 and 5 residues between the NY2R sequence and the 
Blc sequence were deleted to generate pBlc3-NY2T23 and pBlc3-NY2P25, respectively. Table 
S4 in the Supp. Mat. lists all PCR primers that were used. 
 
Calculation of loop mismatch scores between GPCRs and the OmpA scaffold 
The overall topology of the loops is defined by 15 unique distances between the anchor points. 
Likewise, the topology of the 8 anchor points of the four extracellular loops of OmpA is defined 
by 28 unique distances. 24 different modes are possible for arranging three foreign loops on the 
four acceptor sites of the scaffold. To rank them according to the similarity with a GPCR 
structure, a mismatch score was computed based on average distances between the anchor points 
of the extracellular loops in published GPCR crystal structures (i.e. the C" atoms of those residues 
located at the beginning and end of the flanking transmembrane helices) (for a list of the used 
GPCR coordinates see the Supp. Mat.) 
The C" atoms of the residues at the beginning and end of the flanking !-strands in the NMR 
structure of a loop-shortened OmpA variant (2JMM) (Johansson et al., 2007) were considered as 
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the anchor points of the extracellular loops. Then, the distances between the six involved anchor 
points of the three grafted GPCR loops for each of the possible 24 arrangements on the four 
acceptor sites of the OmpA scaffold were calculated and compared to the distances calculated for 
an average GPCR. Mismatch scores were calculated according to  
di, j
j=i+1
6
!
i=1
6
!
 with di,j being the 
difference in separation distance between the anchor points i and j corresponding to one loop in 
an average GPCR and the corresponding distance in OmpA (see also Figure 2).  
 
Synthesis and purification of the neurohormones 
The sequences of porcine NPY (pNPY) (Bader et al., 2001) and PYY (pPYY) (Lerch et al., 
2004) and of bovine PP (bPP) (Lerch et al., 2002) were used throughout this study.  
The synthesis of unlabeled neurohormones was carried out using standard Fmoc-based solid-
phase peptide synthesis using an automated system (ABI433A, Applied Biosystems, Carlsbad, 
California, USA). 15N-labeled neurohormones were produced as described in detail elsewhere 
(Bader et al., 2001; Lerch et al., 2002). 
All peptide masses were confirmed by ESI-MS. 
 
Biosynthesis and purification of OmpA-based receptor constructs 
All genetic deletions/insertions/mutations were performed using the QuikChange mutagenesis 
method. Table S5 in the Supp. Mat. lists all the primers used. The coding region for the 
transmembrane domain (TMD) of OmpA from E. coli (UniProt entry P0A910 positions 22-346 
with a D77E mutation) (Ramakrishnan et al., 2005) served as starting point. 
OmpA loop sequences to be replaced with the Y receptor loop sequences were selected based 
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on a previously described loop-shortening study (Koebnik and Kramer, 1995). Residues H19-
H31, P62-Y72, K107-G118, and I147-P157 correspond to the extracellular loops 1, 2, 3, and 4, 
respectively. According to hydrophobicity plots the N-terminal domain and the extracellular 
loops of the human Y1 receptor (see http://www.gpcr.org/7tm/proteins/npy1r_human) were 
assumed to comprise the stretches M1-I40, Y100-M112, Q177-S210, and F286-N299. Any 
cysteines in these sequences were replaced by serines. The cDNA sequences of these loops were 
optimized by gene synthesis (Microsynth AG, Balgach, Switzerland) to account for optimal E. 
coli codon usage (Kane, 1995; Makrides, 1996). Y receptor N-terminal sequences were as 
described above. 
The chimeric constructs were generated by first deleting all four original OmpA loop 
sequences, followed by insertion of the foreign Y1 receptor loop sequences via QuikChange 
mutagenesis. The desired topological arrangement of the Y receptor loops on the OmpA scaffold 
was achieved in four rounds of mutagenesis, filling three positions with Y1 receptor loops and 
the fourth one with a minimal turn-inducing sequence (Koebnik, 1999a). The construct carrying 
the Y1 receptor N-terminus at the position of the third extracellular loop of OmpA (Y1L3-NY1) 
had the first 40 residues of the human Y1 receptor N-terminally flanked by a (Gly-Ser)3 spacer as 
well as the 3C protease (Pallai et al., 1989) cleavage sequence (LEVLFQGP). 
OmpA and its derivatives were expressed in E. coli BL21(DE3) using the vector pET22b 
(Novagen, Madison, Wisconsin, USA). Unlabeled and 15N-labeled proteins, respectively, were 
expressed in LB rich medium and M9 minimal medium containing 15NH4Cl as the sole nitrogen 
source. Cultures were grown at 37°C and induced with 1 mM isopropyl-!-D-
thiogalactopyranoside (IPTG) at an OD600 of 0.8. Cells were harvested by centrifugation at 4°C 
and cell pellets were frozen at -20°C until processing.  
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All chimeric receptor constructs were obtained as inclusion bodies and purified as described 
previously (Johansson et al., 2007). Inclusion bodies were solubilized in 8 M urea, 10 mM Tris 
pH 8, 1 mM EDTA to a final protein concentration of 20 mg/ml. 
 
Refolding of chimeric GPCR-OmpA receptors 
Buffers for the refolding screens were 10 mM Na-acetate pH 4, 10 mM HEPES/NaOH pH 7, 
10 mM Tris/HCl pH 8.8, and 10 mM Na-borate pH 10, always containing 1 mM EDTA. The 
detergent concentration was chosen to achieve at least a 500-fold excess of detergent over protein 
or twice the critical micellar concentration (cmc) of the detergent. Protein was added, mixed by 
vortexing and incubated at 30°C for 5 h. Refolding efficiency was assessed by "non-denaturing" 
18% SDS-PAGE (Schweizer et al., 1978). 
The solution was then buffer-exchanged in an Amicon Ultra-4 centrifugal concentrator (10 kDa 
MWCO; Millipore, Billerica MA, USA ; cat. no. UFC801024) to NMR buffer (3% w/v DHPC, 
20 mM NaPi pH 6.5, 100 mM NaCl, 10% v/v D2O).  
 
3C protease cleavage of Y1L3-NY1 
0.7 mg of 3C protease (for expression and purification of 3C protease see Supp. Mat.) per mg 
of Y1L3-NY1 protein was added and the solution was incubated at 4ºC for 15 h. 3C protease was 
removed by incubation with Ni-NTA resin (Sigma, Buchs, Switzerland) at 4ºC. 
 
NMR spectroscopy 
All spectra were recorded on Bruker AV-600 or AV-700 spectrometers equipped with 
cryoprobes. Proton chemical shifts were calibrated to the water signal and nitrogen shifts were 
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referenced indirectly to liquid NH3 (Live et al., 1984). 
Proton-nitrogen correlation maps of the receptor constructs were measured as [15N,1H]-TROSY 
experiments. 
Raw data was processed using the Bruker Topspin software version 2.0 or 2.1 and transferred 
to XEASY (Bartels et al., 1995) or CARA (Keller, 2004) for further analysis. 
The reported assignments for pNPY (Bader et al., 2001), pPYY (Lerch et al., 2004), and bPP 
(Lerch et al., 2002) in DPC micelles at pH 4.5 served as the starting points for the assignments of 
the amide resonances of pNPY, pNPY-R33L and pNPY-R35L, pPYY and bPP in DHPC micelles 
at pH 6.5 using a strategy reported by us before (Bader et al., 2001). 
In order to detect interactions of the hormones with the receptor construct via chemical shift 
mapping, 15N-labeled neurohormones were dissolved in 0.25 ml NMR buffer and increasing 
amounts of the refolded receptor constructs (0.5-100 equivalents) were added. In an analogous 
fashion, uniformly 15N-labeled Y1L3 at concentrations between 0.25 and 1 mM was dissolved in 
NMR buffer and TROSY spectra were recorded at 320 K in the presence of increasing amounts 
of unlabeled peptide. 
On- and off-resonance irradiations in the saturation transfer difference (STD) NMR experiment 
(Mayer and Meyer, 1999; Mayer and Meyer, 2001) were applied at -0.5 ppm and 40 ppm, 
respectively. 
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Figure legends 
 
Figure 1: Geometries of GPCRs and !-barrel proteins. A) Ribbon representation of bovine 
rhodopsin with the first, second, and third extracellular loops (e1-3) colored yellow, red, and 
blue, respectively. On the right the arrangement of the extracellular loop anchor points is 
presented as viewed from the extracellular side (same color coding used as in the ribbon 
representation). Each anchor point is labeled by its terminal/initial residue and the TM-helix to 
which it belongs. 
B) Ribbon representation of Blc with its four variable loops colored green and the anchor points 
yellow. On the right the arrangement of the loop anchor points is presented as viewed from the 
top (same color coding as in ribbon representation). Directly connected anchor points are 
indicated by black arrows and labeled with the respective distance. For clarity the N-terminal 310-
helix and the C-terminal "-helix of Blc is omitted in the ribbon representation. 
C) Same representation as in B) for OmpA. 
D) Histograms of the distances between the anchor points for extracellular loops 1, 2, and 3 as 
found in a set of 10 GPCR crystal structures (Supplementary Material and Methods for full list) 
(top panel) and E) for the extracellular loops in the NMR structures of two OmpA structures and 
one loop-shortened OmpA construct (10 conformers each) (bottom panel). Average distances 
between the anchor points for the e1, e2, and e3 loop in the GPCR structures are indicated by 
yellow, red and blue bars, respectively. 
 
Figure 2: Summary of Y2 receptor N-terminus grafting attempts using Blc. A) Blc sequence 
with colored arrows indicating the !-strand secondary structural elements in the crystal structure. 
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Red: additional two-stranded !-sheet which has arisen as a cloning artifact (Schiefner et al., 
2010); yellow: N-terminal 310- and C-terminal "-helix, both characteristic for the lipocalin fold; 
green: eight-stranded !-barrel, the central motif of the lipocalin fold. The sequence 23 to 177 
corresponds to the natural Blc protein, to which a His6 tag was appended at the N-terminus and a 
Strep-tag II at the C-terminus. Residues to which the NY2 sequence has been N-terminally fused 
are shaded in green or red, indicating constructs resulting in soluble or insoluble protein, 
respectively. 
B) Ribbon representation of Blc with the residues to which the NY2 sequence was N-terminally 
fused colored in green or red, as in panel A. The [15N,1H]-HSQC spectra of Blc and the respective 
NY2-grafted/fused constructs are depicted next to the structure. Properly folded constructs are 
characterized by good signal dispersion in the spectra. 
 
Figure 3: Design of Loop-grafted constructs. A) Calculation of the mismatch score (in Å) for all 
24 possible "receptor constructs" (for a description of the calculation procedure see Materials and 
Methods). Constructs displaying the Y receptor extracellular loops in an appropriate topological 
orientation for grafting are colored. The four chimeric GPCR-OmpA constructs selected for 
expression (Y1L1, Y1L2, Y1L3, and Y1L4) are marked in green. 
B) Topography for the selected constructs of the three e1-3 loops of Y1 on the eight-stranded 
OmpA !-barrel. The remaining unused fourth loop of the OmpA scaffold was replaced by a short 
linker sequence. Amino acid sequences for the three Y1 loops as well as the short linker are 
depicted at the bottom. Serine residues highlighted in red correspond to cysteine side chains in 
the natural Y1 sequences, which were substituted to avoid formation of undesired disulfide cross-
links.  
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Figure 4: Folding properties of grafted receptor constructs using non-denaturing SDS-PAGE. A) 
pH dependence of the refolding efficiency of Y1L1 in a variety of different detergents (DDM: "-
dodecyldimaltoside, !-OG: !-octylglucoside, C8E4: tetraethyleneglycol monooctylether, LDAO: 
N-lauryldimethyl amineoxide, DPC: dodecylphosphocholine, DHPC: 
dihexanoylphosphatidylcholine). While refolding is not efficient in all detergents, a clear trend to 
increased efficiency apparent from the presence of a lower band different from the heat-denatured 
(unfolded) species at higher pH is observed. 
B) While Y1L1 and Y1L2 can be refolded with fairly high efficiency at pH 10 in most detergents 
tested, corresponding efficiencies for Y1L3 and Y1L4 are much lower. 
C) Optimization of the refolding procedure towards more gentle conditions (lower temperature, 
slow dilution of the denatured stock solution) results in increased refolding efficiency especially 
for Y1L3 and Y1L4. 
 
Figure 5: Interaction studies with the “split” receptor model, that additionally displays the N-
terminal domain of Y1, Y1L3-NY1. A) Schematic representation of the construct. The OmpA 
beta-barrel is shown in cyan, the grafted eY1 loops in dark red, the (Gly-Ser)3-linker and 3C 
protease cleavage site in yellow and NY1 in red. B) SDS-PAGE of Y1L3-NY1 under different 
conditions: a different migration behavior under non-denaturing (lane 2) and denaturing (lane 3) 
conditions indicates successful refolding of the construct. After treatment with 3C protease the 
construct shows the same migration behavior (lane 4) as before (lane 2) under non-denaturing 
conditions. Under denaturing conditions two bands with sizes with sizes of ca. 14 kDa can be 
seen after cleavage with 3C protease (lane 5). C) The chemical shift changes observed in the 
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[15N,1H]-HSQC spectrum of NPY upon addition of 20 eq. of cleaved Y1L3-NY1 protein plotted 
for each residue and color-coded onto the "-helical structure of NPY where gray indicates no 
change and the intensity of red is proportional to the chemical shift change. Changes are most 
prominent on one side of the helix. A helical wheel representation of the C-terminal "-helix 
(L17-Q34) of NPY shows that this side comprises exclusively hydrophobic and aromatic 
residues. 
 
Figure 6: Interaction studies between peptide hormones and receptor constructs using NMR. 
[15N,1H]-HSQC spectra of the 15N-NPY in 3% DHPC, 20 mM phosphate pH 6.5, 100 mM NaCl 
at 310K A) in the absence, B) in the presence of 20 eq. of unlabeled Y1L3 protein and C) in 
presence of 20 eq. of unlabeled Y1L3 protein and 50 equivalents of unlabeled NPY.  
[15N,1H]-HSQC spectra of mutant peptide 15N-NPY-R35L D) in the absence, E) in the presence of 
20 equivalents of unlabeled Y1L3 protein. 
[15N,1H]-HSQC spectra of mutant peptide 15N-NPY-R33L F) in the absence, G) in the presence of 
20 equivalents of unlabeled Y1L3. 
The relative residue-specific volume change of H) NPY, I) PYY, and J) PP resonances upon 
addition of Y1L3 protein plotted for each residue. The relative volume change is color-coded 
onto the structure of the (micelle-bound) species of each neurohormone, with gray stretches 
indicating no change and the intensity of the red color being proportional to the relative volume 
change. 
 
 
Figures Walser et al.
June 16, 2012
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